FDA News Digest
January 28, 2008
_____________________________________
IN THIS WEEK'S ISSUE
» News
» Upcoming Public Meetings
» Consumer Health Information
To access the RSS feed of FDA news releases, go to http://www.fda.gov/bbs/topics/news/rssPress.xml. [What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]
___________________________________________
SAFETY ALERTS/RECALLS
Syringe Recall:
FDA has announced a nationwide recall of all lots of heparin and saline pre-filled flush syringes manufactured by AM2 PAT, Inc. under the brand names Sierra Pre-filled, Inc. and B. Braun. Two lots have been found to be contaminated with Serratia marcescens, a bacterium that can cause serious injury or death. The syringes are sold in fill sizes of 3mL, 5mL and 10mL and syringe sizes of 6mL and 12mL.
Food Recalls:
› Shiloh Farms Organic Unhulled Sesame Seeds (12-oz. size)
Reason for recall: possible Salmonella contamination
http://www.fda.gov/oc/po/firmrecalls/shilohfarms01_08.html
› Zebra brand sweetened lotus root seed (6-oz. size) and Zebra brand sweetened coconut (6-oz. size)
Reason for recall: sulfites in product not declared on label
http://www.fda.gov/oc/po/firmrecalls/domega01_08.html
products from the past 60 days, go to http://www.fda.gov/opacom/7alerts.html.
To access the RSS feed of FDA recalls information, go to http://www.fda.gov/oc/po/firmrecalls/rssRecalls.xml
[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]
__________________________________________________________________
UPCOMING PUBLIC MEETINGS
Feb. 1 -- Drug Safety and Risk Management Advisory Committee
Under discussion: pending application for a new drug to treat iron deficiency anemia
Location: Silver Spring, Md.
http://www.fda.gov/OHRMS/DOCKETS/98fr/E7-24003.htm
Feb. 5 -- Cellular, Tissue and Gene Therapies Advisory Committee
Under discussion: updates of ongoing research programs
Location: Bethesda, Md., and by teleconference
http://www.fda.gov/OHRMS/DOCKETS/98fr/E7-25124.htm
Feb. 6 -- Psychopharmacologic Drugs Advisory Committee
Under discussion: pending application for a new schizophrenia treatment
Location: Silver Spring, Md.
http://www.fda.gov/OHRMS/DOCKETS/98fr/E7-24627.htm
For a complete list of FDA meetings, seminars, and other public events, go to
Here's what's in the spotlight this week:
› OTC Cough and Cold Products: Not for Infants and Children Under 2 Years of Age
Questions and Answers for Consumers
http://www.fda.gov/consumer/updates/coughcold011708.html
› Beware of Fake Erectile Dysfunction Products Being Sold Online
http://www.fda.gov/consumer/updates/erectiledysfunction010408.html
Thanks for subscribing to FDA News Digest.
Comments about FDA News Digest?
Send an e-mail to fdanewsdigest@xxxxxxxxxv.
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@xxxxxxxxxxxxxxx.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420